Inovio Pharmaceuticals
INO
INO
182 hedge funds and large institutions have $201M invested in Inovio Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 58 increasing their positions, 39 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
6% less call options, than puts
Call options by funds: $2.42M | Put options by funds: $2.57M
1% less funds holding
Funds holding: 184 → 182 (-2)
Holders
182
Holding in Top 10
–
Calls
$2.42M
Puts
$2.57M
Top Buyers
| 1 | +$3.62M | |
| 2 | +$3.47M | |
| 3 | +$2.79M | |
| 4 |
D.E. Shaw & Co
New York
|
+$2.68M |
| 5 |
Barclays
London,
United Kingdom
|
+$1.98M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$4.63M | |
| 3 | -$2.47M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.43M |
| 5 |
Two Sigma Advisers
New York
|
-$1.33M |